Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Home

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Diabetes/Metabolism Research and Reviews|March 29, 2002
Therapeutic targets in the management of Type 1 diabetesP D Home
Diabetic Medicine : a Journal of the British Diabetic Association|September 9, 2008
Impact of the UKPDS--an overviewP D Home
BMJ (Clinical Research Ed.)|July 15, 1995
Targets for glycated haemoglobin. Glycated haemoglobin targets are attainableP D Home
Diabetes, Obesity & Metabolism|June 5, 2015
Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?P D Home
The British Journal of Surgery|February 19, 2009
Surgery and the prevention of limb loss in diabetesP D Home
Diabetes, Obesity & Metabolism|January 28, 2014
The vexed question of hypoglycaemia and health economicsP D Home
Diabetologia|March 27, 2007
Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259-267P D Home
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 16, 1999
Rapid-acting insulin secretagogues: a clinical need?P D Home
Pharmacoeconomics|December 9, 1994
Pharmacoeconomics of diabetes surveillance and detection programmesP D Home
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1995
[Respective contributions of the method of insulin injection and its absorption by subcutaneous route in the etiopathogenesis of unstable diabetes]P D Home
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Diabetes/Metabolism Research and Reviews|March 29, 2002
Therapeutic targets in the management of Type 1 diabetesP D Home
Diabetic Medicine : a Journal of the British Diabetic Association|September 9, 2008
Impact of the UKPDS--an overviewP D Home
BMJ (Clinical Research Ed.)|July 15, 1995
Targets for glycated haemoglobin. Glycated haemoglobin targets are attainableP D Home
Diabetes, Obesity & Metabolism|June 5, 2015
Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?P D Home
The British Journal of Surgery|February 19, 2009
Surgery and the prevention of limb loss in diabetesP D Home
Diabetes, Obesity & Metabolism|January 28, 2014
The vexed question of hypoglycaemia and health economicsP D Home
Diabetologia|March 27, 2007
Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259-267P D Home
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 16, 1999
Rapid-acting insulin secretagogues: a clinical need?P D Home
Pharmacoeconomics|December 9, 1994
Pharmacoeconomics of diabetes surveillance and detection programmesP D Home
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1995
[Respective contributions of the method of insulin injection and its absorption by subcutaneous route in the etiopathogenesis of unstable diabetes]P D Home
Pageof 17